Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 21, 2022, Jane Kiernan, a member of the Board of Directors of Salona Global Medical Device Corporation (the "Company"), notified the Company of her retirement from the Company's Board of Directors to devote more time to other pursuits, effective January 21, 2022. Ms. Kiernan did not advise the Company of any disagreement with the Company on any matter relating to its operations, policies or practices. Effective upon Ms. Kiernan's resignation as a director, the size of the Company's Board of Directors will be reduced from four to three directors.

Item 7.01 Regulation FD Disclosure.

The Company posted to its website, under the Downloads tab, a presentation (the "Corporate Presentation") which will be utilized in various meetings with securities analysts, investors and others. The Corporate Presentation is attached hereto pursuant to Regulation FD as Exhibit 99.1.

On January 24, 2022, the Company issued a press release announcing that had entered into a term sheet dated December 10, 2021 for the acquisition of a medical device sales and marketing business serving the mid-western United States, and also announcing the matters set forth in Item 5.02. The press release is attached hereto pursuant to Regulation FD as Exhibit 99.2.

The information in this Item 7.01, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of Section 18, (and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933 or the Exchange Act), except as shall be expressly set forth by specific reference in any such filing. This Current Report will not be deemed an admission as to the materiality of any information contained in this Item 7.01, including Exhibits 99.1 and 99.2.

The exhibit to this report may include certain statements concerning expectations for the future that are forward-looking statements as defined by federal securities law. It is important to note that the Company's actual results could differ materially from those projected in such forward-looking statements. Factors that could affect those results include those mentioned in the Company's Quarterly Report on Form 10-Q for the quarter ended November 30, 2021 and other documents that the Company has filed with the Securities and Exchange Commission. The Company does not intend to update these statements unless required by the securities laws to do so, and the Company undertakes no obligation to publicly release the result of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this report or to reflect the occurrence of unanticipated events.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.



Exhibit No.  Description
  99.1         Corporate Presentation of Salona Global Medical Device Corporation
             (furnished herewith).
  99.2         Press Release of Salona Global Medical Device Corporation dated
             January 24, 2022.
104          Cover Page Interactive Data File (embedded within the Inline XBRL
             document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses